| Literature DB >> 24031637 |
Martha C Domínguez1, Norma Enith González, Adalberto Sánchez, Felipe García Vallejo.
Abstract
Although the infection of HTLV-1 to cell components of the mouth have been previously reported, there was not until this report, a detailed study to show the characteristics of such infection. From 14 Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (HAM/TSP) patients and 11 asymptomatic carrier individuals (AC) coming from HTLV-1 endemic areas of southwest Pacific of Colombia, infected oral mucosa cells were primary cultured during five days. These cell cultures were immunophenotyped by dual color fluorescence cell assortment using different lymphocyte CD markers and also were immunohistochemically processed using a polyclonal anti-keratin antibody. Five days old primary cultures were characterized as oral keratinocytes, whose phenotype was CD3- /CD4-/CD8-/CD19-/CD14-/CD45-/A575-keratin+. From DNA extracted of primary cultures LTR, pol, env and tax HTLV-1 proviral DNA regions were differentially amplified by PCR showing proviral integration. Using poly A+ RNA obtained of these primary cultures, we amplify by RT-PCR cDNA of tax and pol in 57.14% (8/14) HAM/TSP patients and 27.28% (3/11) AC. Tax and pol poly A+ RNA were expressed only in those sIgA positive subjects. Our results showed that proviral integration and viral gene expression in oral keratinocytes are associated with a HTLV-1 specific local mucosal immune response only in those HTLV-1 infected individuals with detectable levels of sIgA in their oral fluids. Altogether the results gave strong evidence that oral mucosa infection would be parte of the systemic spreading of HTLV-1 infection.Entities:
Keywords: Human T-Lymphotropic virus type 1; Oral keratinocytes; Oral mucosa; Proviral integration; sIgA
Year: 2011 PMID: 24031637 PMCID: PMC3768932 DOI: 10.1590/S1517-83822011000100040
Source DB: PubMed Journal: Braz J Microbiol ISSN: 1517-8382 Impact factor: 2.476
Figure 2.Reactivity detected by western blot in plasma and OF against HTLV-1 proteins of one HAM/TSP patient from southwest Colombia. (A). Western blot using the commercial HTLV blot 2.4 assay kit (Genelabs® Diagnostics Pte Ltd. Singapore Science Park. Singapore). (1) plasma control for HTLV-1 included with the kit; (2) plasma control for HTLV-2 included with the kit (3) Anti-IgG HTLV-1 in plasma; (4) Anti-IgG HTLV-1 in OF; (5) Anti-sIgA in OF; (6) Negative plasma control. (B). Western blot with a Tax recombinant protein of a HAM/TSP patient. (1) anti-r-tax -IgG in plasma. (2) anti-r-tax -IgG in OF. (3) anti-r-tax-sIgA in OF (4) Negative OF control. (C). Frequencies of sIgA HTLV-1 specific class reactivity of HAM/TSP patients and AC OF from southwest Colombia against the different HTLV-1 proteins detected by western blot. (HAM/TSP). Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy. (AC). Asymptomatic Carrier.
Reactivity of plasma and OF to HTLV-1 antigens as recorded by the ELISA Murex HTLV I + II (Murex Biotech Limited. Dartford. UK) diagnostic kit.
| IgG | IgM | sIgA | IgG | IgM | sIgA | sIgA-Anti-Tax | |
| HAM/TSP | 14/14 | 11/14 | 0/14 | 14/14 | 11/14 | 10/14 | 8/14 |
| AC (a) | 8/11 | 2/11 | 0/11 | 8/11 | 2/11 | 3/11 | 1/11 |
| P (b) | 0.07NS | 0.004 | 1.00 NS | 0.07 NS | 0.004 | 0.04 | 0.03 |
Frequencies of HTLV-1 proviral regions amplified by PCR from DNA of oral keratinocytes from patients with HAM/TSP and asymptomatic carriers (AC)
| 737 | 10/14 | 6/11 | 0.43NS | |
| 189 | 11/14 | 7/11 | 0.65NS | |
| 159 | 9/14 | 5/11 | 0.43NS | |
| 1033 | 9/14 | 9/11 | 0.41NS |
(bp) base pair.
P values calculated with a two tails Fisher exact test. (NS), no statistically significant differences.